Complex Regional Pain Syndrome clinical trials at UCSF
2 in progress, 1 open to eligible people
Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain
open to eligible people ages 22-80
Chronic pain affects 1 in 4 US adults, and many cases are resistant to almost any treatment. Deep brain stimulation (DBS) holds promise as a new option for patients suffering from treatment-resistant chronic pain, but traditional approaches target only brain regions involved in one aspect of the pain experience and provide continuous 24/7 brain stimulation which may lose effect over time. By developing new technology that targets multiple, complimentary brain regions in an adaptive fashion, the investigators will test a new therapy for chronic pain that has potential for better, more enduring analgesia.
San Francisco, California
TARGET Post-Approval Study
Sorry, in progress, not accepting new patients
The purpose of this prospective, multicenter, single arm post-approval study is to demonstrate continued safety of the Axium and Proclaim Neurostimulator System for dorsal root ganglion (DRG) stimulation. The primary endpoint is the 12-month serious adverse event rate for permanent implants.
San Francisco, California and other locations
Our lead scientists for Complex Regional Pain Syndrome research studies include Prasad Shirvalkar.
Last updated: